NCT05537519View on ClinicalTrials.gov

Phage Therapy for the Treatment of Urinary Tract Infection

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

July 28, 2023

Study Completion Date

June 30, 2024

Conditions
Recurrent Urinary Tract Infection
Interventions
BIOLOGICAL

Phage Therapy

3-phage cocktail comprised of HP3, HP3.1 and ES19

Trial Locations (1)

M6R 1B5

St. Joseph's Health Centre, Toronto

Sponsors
All Listed Sponsors
collaborator

Applied Health Research Centre

OTHER

lead

Unity Health Toronto

OTHER

NCT05537519 - Phage Therapy for the Treatment of Urinary Tract Infection | Biotech Hunter | Biotech Hunter